Abstract
Arkema has led a series B financing round for the 3-D printing polymer maker Adaptive3D. Arkema supplies some of the raw materials for Adaptive3D’s one-part, light-cured resins, which are sold into markets including health care, oil and gas, and transportation. West Pharmaceutical Services and Clear Fir Partners also participated in the series B round, as did the venture capital arm of the chip manufacturing equipment firm Applied Materials. Applied co-led Adaptive3D’s series A with DSM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
